A Randomized, Double-blind, Placebo/Active-controlled, Single/Multiple Dose Phase 1 Clinical Study to Investigate the Safety/Tolerability and PK/PD of YH12852 After Oral Administration in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
Price : $35 *
At a glance
- Drugs YH 12852 (Primary) ; Prucalopride
- Indications Constipation; Irritable bowel syndrome
- Focus Adverse reactions
- Sponsors Yuhan
- 07 May 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 14 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Dec 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000881).